fda approved glutathione 2018 highlights concerns with using dietary ingredient to compound sterile injectables FDA Advisory No.2026-0015 || Public
Description
These include the mitigation of intestinal inflammation, suppression of tumor proliferation, and resolution of gut dysbiosis (207)
Whether cysteine S -conjugates, whose elimination products are very reactive, damage the gut and bile duct remains to be determined
Carbon source and phosphate abundance also affect the production of ROS and methylglyoxal [54,55]
McCarty et al
